95.13MMarket Cap-2315P/E (TTM)
3.5465High3.3700Low307.33KVolume3.5000Open3.5200Pre Close1.07MTurnover1.98%Turnover RatioLossP/E (Static)27.03MShares24.710052wk High0.83P/B54.53MFloat Cap1.620052wk Low--Dividend TTM15.49MShs Float1889.9991Historical High--Div YieldTTM5.01%Amplitude1.6200Historical Low3.4690Avg Price1Lot Size
VistaGen Therapeutics Stock Forum
VistaGen Therapeutics GAAP EPS of -$1.52 misses by $1.16, revenue of $1.06M beats by $0.86M
Jun. 11, 2024 4:23 PM ETVistagen Therapeutics, Inc. (VTGN) StockBy: Mary Christine Joy, SA News Editor
VistaGen Therapeutics press release (NASDAQ:VTGN): Q4 GAAP EPS of -$1.52 misses by $1.16.
Revenue of $1.06M (vs. -$0.23M last year) beats by $0.86M.
Shares +0.8%.
Registration-directed fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder...
Vistagen Reports FY24 Net Loss Of $(29.4)M Vs $(59.2)M Last Year
238k shares bought 5.4
No comment yet